Day 3 of the ESMO - Eur. Oncology ACADEMY: great hematology session

The phenotypic landscape of essential human genes: ⁦⁦Cell⁩ 31 million cells! 5,072 essential genes! 🤯🤯🤯 cell.com/cell/fulltext/…

3 days ago the earthquake was forecasted with accuracy. This makes you wonder if measures could have been taken to save lives?

Blessed are those who update their Declaration of Interest on #ESMO website. Sincerely, anyone who submitted a last minute #Abstract today. #ESMO2023

First day of 6th Symposium iTOX 2023 on #Cancer #immunotherapy Adverse Events Gustave Roussy Université Paris-Saclay Pro @SciencesCancer Faculté de Médecine Paris-Saclay with ariane laparra Audrey Perret F-X Danlos Layale Rached Stéphane Champiat J-M Michot

Are you ready to get your knowledge on cancer updated? ESMO - Eur. Oncology #ESMO2023

Cleaner air to breathe. There is a growing body of evidence on the link between #AirPollution & #CancerRisk. ESMO is committed to disseminating science & knowledge to facilitate political actions, providing citizens with a cleaner atmosphere. 📌ow.ly/tkoW50PYXCR

💫 Happy to share our editorial in ESMO Open on access to clinical trials in older patients 👨‍🦳👵 with cancer. How can we be more inclusive 💪? SIOG Young SIOG @frelaut_m layal abi rached authors.elsevier.com/sd/article/S20…

Dans les congrès il faut marcher Beaucoup Et aller voir les posters Souvent très intéressants Ici des données précieuses de toxicités de l’association chimio + immuno (Pembrolizumab) dans les cancers du sein en neoadjuvant Merci 🙏 Martina Spotti Layale Rached et al de

What an achievement !! Big congrats 🎉 to all rising stars ✨ at DITEP presenting their work today and more to come tomorrow Gustave Roussy Layale Rached Julieta Rodriguez @MattePaul1 Matthieu Delaye Kaissa Ouali Future is bright 😃

Presenting efficacy and safety of pembrolizumab in TNBC in a real-world setting #ESMO23 with Martina Spotti Layale Rached Capu B Madona Sakkal, MD Elie Rassy Barbara Pistilli Stéphane Champiat Houssam El Masri Next steps exploring blood based and imaging biomarkers! Gustave Roussy

Simply "presidential"! Tom Powles presents the first combinations thats beats chemotherapy in 1L mUC for survival!! At 17.2mo f/up PFS HR=0.45, OS HR=0.47 Congrats to the investigators, scientific community and patients! #ESMO23 ESMO - Eur. Oncology OncoAlert

New treatments New toxicities New solutions Excellent excellent talk by Yohann Loriot #ESMO23 ESMO - Eur. Oncology OncoAlert

“ Personalized medicine is finding the right medication, for the right patient, at the right dose” Mark J. Ratain #ESMO23 ESMO - Eur. Oncology

Great message from this morning panel on lung cancer in #SIOG2023. When assessing an oncology geriatric patient think about the “4M” rule: -What Matters most to the patient? -Medications -Mobility -Mentation SIOG

Thank you SIOG Young SIOG for the opportunity to present our work at the #SIOG2023. Although the rate of high grade adverse events was similar among older patients treated with Chemo-immunotherapy, treatment discontinuation rates were higher. Capu B Gustave Roussy

Excellent presentation by Capu B on immunotherapy in older patients at #SIOG2023. With more data emerging on safety and efficacy of immunotherapy in the geriatric population, the picture is becoming clearer. SIOG Young SIOG

So happy and proud 👏🏻 to work with those 2 amazing women Julieta Rodriguez Layale Rached Young SIOG SIOG Gustave Roussy #SIOG2023 Safe returns to everyone 🌏🌍🌎 See you next year 🇨🇦🍁

What do we know about ADCs in the geriatric population? Find out in our latest article, revealing state of the art advancements revolutionizing treatment for the elderly. Capu B fx danlos Kaissa Ouali Claudia Parisi arthur geraud sciencedirect.com/science/articl…

Going on our 2nd journey of the 7th Symposium on #Cancer #Immunotherapy A.E. (iTOX2024) with Stéphane Champiat giving an interesting talk on Tarlatamab #AE Gustave Roussy ParisSaclay Université Paris-Saclay Pro @SciencesCancer with F-X Danlos Pr LAMBOTTE Pr MARABELLE Dr LAPARRA Layale Rached